Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy
- 30 October 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 69 (18) , 1751-1760
- https://doi.org/10.1212/01.wnl.0000268699.34614.d3
Abstract
Objective: To assess the efficacy and tolerability of adjunctive levetiracetam in patients with uncontrolled generalized tonic-clonic (GTC) seizures associated with idiopathic generalized epilepsies (IGE).Keywords
This publication has 28 references indexed in Scilit:
- ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and SyndromesEpilepsia, 2006
- Practical Management Issues for Idiopathic Generalized EpilepsiesEpilepsia, 2005
- Fast and Sustained Efficacy of Levetiracetam during Titration and the First 3 Months of Treatment in Refractory EpilepsyEpilepsia, 2005
- Genetic Architecture of Idiopathic Generalized Epilepsy: Clinical Genetic Analysis of 55 Multiplex FamiliesEpilepsia, 2004
- Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating MonotherapyEpilepsia, 2000
- Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial SeizuresEpilepsia, 2000
- Effect of Levetiracetam on Epilepsy‐Related Quality of LifeEpilepsia, 2000
- Pharmacokinetic profile of levetiracetamPharmacology & Therapeutics, 2000
- Double‐Blind, Placebo‐Controlled, Lamotrigine in Treatment‐Resistant Generalised EpilepsyEpilepsia, 1998
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989